SE215464C1 - - Google Patents

Info

Publication number
SE215464C1
SE215464C1 SE749859A SE749859A SE215464C1 SE 215464 C1 SE215464 C1 SE 215464C1 SE 749859 A SE749859 A SE 749859A SE 749859 A SE749859 A SE 749859A SE 215464 C1 SE215464 C1 SE 215464C1
Authority
SE
Sweden
Application number
SE749859A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of SE215464C1 publication Critical patent/SE215464C1/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C12R1/465—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE749859A 1958-08-12 1959-08-11 SE215464C1 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25905/58A GB877732A (en) 1958-08-12 1958-08-12 The antibiotic rifomycin, its components and methods of preparing same

Publications (1)

Publication Number Publication Date
SE215464C1 true SE215464C1 (sv) 1967-09-26

Family

ID=10235244

Family Applications (1)

Application Number Title Priority Date Filing Date
SE749859A SE215464C1 (sv) 1958-08-12 1959-08-11

Country Status (5)

Country Link
US (1) US3150046A (sv)
BE (1) BE581408A (sv)
ES (1) ES251407A1 (sv)
GB (1) GB877732A (sv)
SE (1) SE215464C1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338786A (en) * 1966-07-29 1967-08-29 American Cyanamid Co Antibiotic av290 and production thereof
SU465795A3 (ru) * 1972-05-05 1975-03-30 Группо Лепетит (Фирма) Способ получени рифамицина в.
ES415056A1 (es) * 1972-11-29 1976-02-16 Archifar Ind Chim Trentino Procedimiento de produccion de rifamicina b.
US4267274A (en) * 1973-04-26 1981-05-12 Gruppo Lepetit S.P.A. Streptomyces mediterranei mutant capable of production of rifamycin B
US3884763A (en) * 1974-03-11 1975-05-20 Pfizer Production of rifamycin s and rifamycin sv by micromonospora chalcea
US4220657A (en) * 1978-08-11 1980-09-02 Johnson Lewis A Method for treatment of human eye disease
US4292327A (en) * 1978-08-11 1981-09-29 Johnson Lewis A Method for treatment of human eye disease
DK3004162T3 (da) 2013-05-31 2020-05-18 Genentech Inc Anti-væg-teichoin-antistoffer og konjugater
US9803002B2 (en) 2013-05-31 2017-10-31 Genentench, Inc. Anti-wall teichoic antibodies and conjugates
CA2965540A1 (en) 2014-12-03 2016-06-09 Genentech, Inc. Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof
BR112017011478A2 (pt) 2014-12-03 2018-02-27 Genentech, Inc. composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante
JP6705904B2 (ja) 2016-03-04 2020-06-03 ジェネンテック， インコーポレイテッド 抗体−リファマイシン複合体の製造プロセス

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2999048A (en) * 1957-12-18 1961-09-05 Olin Mathieson Nancimycin, dihydronancimycin, their salts, and method of manufacture

Also Published As

Publication number Publication date
BE581408A (fr) 1959-12-01
GB877732A (en) 1961-09-20
ES251407A1 (es) 1960-03-01
US3150046A (en) 1964-09-22

Similar Documents

Publication Publication Date Title
SE215464C1 (sv)
AT214638B (sv)
AT221043B (sv)
AT217439B (sv)
AT215747B (sv)
AT213908B (sv)
AT215751B (sv)
AT216227B (sv)
AT213670B (sv)
AT214348B (sv)
AT217982B (sv)
AT216831B (sv)
AT215738B (sv)
DE1222270C2 (sv)
AT213631B (sv)
AT216803B (sv)
AT216771B (sv)
AT216749B (sv)
AT219815B (sv)
AT213558B (sv)
AT219868B (sv)
AT214270B (sv)
DE1065579B (sv)
BE555601A (sv)
BE543487A (sv)